PIK3CA and invasive breast carcinoma: Analysed by the Molecular Tumor Board Portal, PIK3CA bears somatic protein-affecting mutations in 35.4% of the invasive breast carcinoma samples (n=1297) and 14.0% of the pan-cancer samples (n=10703) [22] (Figure 4(a)).